CA
NZ
UK
AU
IND
US
Modular Medical, Inc. (NASDAQ: MODD) shares closed up 8% at $3.68 after the company secured a contract with a national U.S. pharmacy benefit manager for its Pivot tubeless insulin patch pump.
Jaguar Health, Inc. (NASDAQ: JAGX) shares closed down 14% at $0.60 after the company broadened compassionate-use availability for oral crofelemer to treat an infant with congenital sodium diarrhea-linked intestinal failure.
A NASDAQ-listed healthcareRoyaltycompany is trading sharply lower today despite recent bullish analyst price target increases, a decline that sits at odds with the sell-side's improving view of the stock. Royalty Pharma (NASDAQ:RPRX) shares are declining sharply, tracking broad weakness in the healthcare sector, which …
A NASDAQ-listed clinical-stage biotechnology company is trading sharply lower today despite presenting an updated, largely positive pipeline outlook, a reaction that runs counter to what would typically be viewed as encouraging news. Sana Biotechnology (NASDAQ:SANA) management presented at the Wells Fargo Healthcare Conference, with …
A NYSE-listed medical device company is trading sharply lower today, hitting a new 52-week low, despite having beatenEarningsestimates in its most recent quarter, a reaction that runs counter to what would typically be viewed as positive news. Stryker (NYSE:SYK), speaking through CFO Preston Wells …
A NASDAQ-listed biotechnology company is trading sharply lower today despite raising its full-year guidance following a strong quarter, an outcome that would typically be read as good news for the stock. BioCryst Pharmaceuticals (NASDAQ:BCRX) is underperforming the broader healthcare sector even after reporting a …
A NASDAQ-listed clinical-stage biotechnology company is trading lower today despite presenting durable clinical data for its lead gene-editing program, a reaction that runs counter to what would typically be viewed as positive news. Beam Therapeutics (NASDAQ:BEAM) presented updated Phase 1/2 data for BEAM-302, its …
Compass Pathways (NASDAQ:CMPS) shares are rallying alongside a broad, sector-wide surge in biotechnology stocks, with peers including Roivant Sciences (NASDAQ:ROIV), up 17.7%, and Soleno Therapeutics (NASDAQ:SLNC), up 10%, also posting sharp gains despite limited company-specific news across the sector today. Compass is a clinical-stage …
Dyne Therapeutics (NASDAQ:DYN) shares are plunging after peer Novartis (NYSE:NVS) reported that its Phase 3 HARBOR study of del-desiran for myotonic dystrophy type 1 failed to hit statistical significance on its primary endpoint of video hand opening time versus placebo. Dyne is a clinical-stage …
Enovis (NYSE:ENOV) shares surged after the company announced a binding offer to acquire eCential Robotics for €155 million. Insider buying momentum has continued alongside the deal news, with CEO Damien McDonald and Chief Administrative Officer Oliver Engert making repeated open-market purchases in recent weeks, …
Please wait processing your request...